{"id":389753,"date":"2020-11-30T11:46:30","date_gmt":"2020-11-30T16:46:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=389753"},"modified":"2020-11-30T11:46:30","modified_gmt":"2020-11-30T16:46:30","slug":"sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","title":{"rendered":"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS"},"content":{"rendered":"

<\/p>\n

Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS <\/b><\/p>\n

NEW YORK–(BUSINESS WIRE<\/a>)–
\nHalper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) and Viracta Therapeutics, Inc. is fair to Sunesis shareholders.\n<\/p>\n

\nHalper Sadeh encourages Sunesis shareholders to click here to learn more about their legal rights and options<\/a><\/b> or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com<\/a> or zhalper@halpersadeh.com<\/a>.\n<\/p>\n

\nUnder the terms of the merger agreement, Viracta stockholders will receive shares of newly issued Sunesis common stock. Viracta stockholders are expected to own approximately 86% and Sunesis stockholders will own approximately 14% of the combined company on a fully diluted basis, which may be subject to adjustment based on Sunesis\u2019 net cash.\n<\/p>\n

\nThe investigation concerns whether Sunesis and its board of directors violated the federal securities laws and\/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Sunesis shareholders; and (2) disclose all material information necessary for Sunesis shareholders to adequately assess and value the merger consideration.\n<\/p>\n

\nOn behalf of Sunesis shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.\n<\/p>\n

\nHalper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.\n<\/p>\n

\nAttorney Advertising. Prior results do not guarantee a similar outcome.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20201130005751\/en\/<\/a><\/span><\/p>\n

\nHalper Sadeh LLP
\n
Daniel Sadeh, Esq.
\n
Zachary Halper, Esq.
\n
(212) 763-0060
\n
sadeh@halpersadeh.com
\n<\/a>
zhalper@halpersadeh.com
\n<\/a>
https:\/\/www.halpersadeh.com<\/a><\/p>\n

KEYWORDS:<\/b> New York United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) and Viracta Therapeutics, Inc. is fair to Sunesis shareholders. Halper Sadeh encourages Sunesis shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. Under the terms of the merger agreement, Viracta stockholders will receive shares of newly issued Sunesis common stock. Viracta stockholders are expected to own approximately 86% and Sunesis … <\/p>\n

Continue reading “Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-389753","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) and Viracta Therapeutics, Inc. is fair to Sunesis shareholders. Halper Sadeh encourages Sunesis shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. Under the terms of the merger agreement, Viracta stockholders will receive shares of newly issued Sunesis common stock. Viracta stockholders are expected to own approximately 86% and Sunesis … Continue reading "Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-30T16:46:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS\",\"datePublished\":\"2020-11-30T16:46:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"},\"wordCount\":348,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\",\"name\":\"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2020-11-30T16:46:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","og_locale":"en_US","og_type":"article","og_title":"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS - Market Newsdesk","og_description":"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS NEW YORK–(BUSINESS WIRE)– Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) and Viracta Therapeutics, Inc. is fair to Sunesis shareholders. Halper Sadeh encourages Sunesis shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. Under the terms of the merger agreement, Viracta stockholders will receive shares of newly issued Sunesis common stock. Viracta stockholders are expected to own approximately 86% and Sunesis … Continue reading \"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-30T16:46:30+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS","datePublished":"2020-11-30T16:46:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"},"wordCount":348,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/","name":"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en","datePublished":"2020-11-30T16:46:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20201130005751r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sunesis-merger-investigation-halper-sadeh-llp-announces-investigation-into-whether-the-merger-of-sunesis-pharmaceuticals-inc-is-fair-to-shareholders-investors-are-encouraged-to-contact-the-firm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sunesis Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Sunesis Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm \u2013 SNSS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389753","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=389753"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389753\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=389753"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=389753"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=389753"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}